67 related articles for article (PubMed ID: 29980977)
1. The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study.
Sham JG; Ejaz A; Gage MM; Bagante F; Reames BN; Maithel S; Poultsides GA; Bauer TW; Fields RC; Weiss MJ; Marques HP; Aldrighetti L; Pawlik TM; He J
J Gastrointest Surg; 2019 Mar; 23(3):484-491. PubMed ID: 29980977
[TBL] [Abstract][Full Text] [Related]
2. A multicenter propensity score analysis of significance of hepatic resection type for early-stage hepatocellular carcinoma.
Tang SC; Zhang KL; Lin KY; Tang YD; Fu J; Zhou WP; Zhang JX; Kong J; He XL; Sun ZH; Luo C; Liu HZ; Lai YP; Zeng YY
Hepatol Int; 2024 Apr; 18(2):623-635. PubMed ID: 37880566
[TBL] [Abstract][Full Text] [Related]
3. T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases.
Katz SC; Donkor C; Glasgow K; Pillarisetty VG; Gönen M; Espat NJ; Klimstra DS; D'Angelica MI; Allen PJ; Jarnagin W; Dematteo RP; Brennan MF; Tang LH
HPB (Oxford); 2010 Dec; 12(10):674-83. PubMed ID: 21083792
[TBL] [Abstract][Full Text] [Related]
4. Liver resection and ablation for metastatic melanoma: A single center experience.
Doussot A; Nardin C; Takaki H; Litchman TD; D'Angelica MI; Jarnagin WR; Postow MA; Erinjeri JP; Kingham TP
J Surg Oncol; 2015 Jun; 111(8):962-8. PubMed ID: 26073980
[TBL] [Abstract][Full Text] [Related]
5. Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study.
Sadot E; Reidy-Lagunes DL; Tang LH; Do RK; Gonen M; D'Angelica MI; DeMatteo RP; Kingham TP; Groot Koerkamp B; Untch BR; Brennan MF; Jarnagin WR; Allen PJ
Ann Surg Oncol; 2016 Apr; 23(4):1361-70. PubMed ID: 26597365
[TBL] [Abstract][Full Text] [Related]
6. When should a liver resection be performed in patients with liver metastases from neuroendocrine tumours? A systematic review with practice recommendations.
Lesurtel M; Nagorney DM; Mazzaferro V; Jensen RT; Poston GJ
HPB (Oxford); 2015 Jan; 17(1):17-22. PubMed ID: 24636662
[TBL] [Abstract][Full Text] [Related]
7. Preoperative anemia: impact on short- and long-term outcomes following curative-intent resection of gastroenteropancreatic neuroendocrine tumors.
Xiang JX; Nan YL; He J; Lopez-Aguiar AG; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Maithel SK; Lv Y; Zhang XF; Pawlik TM
J Gastrointest Surg; 2024 Jun; 28(6):852-859. PubMed ID: 38538480
[TBL] [Abstract][Full Text] [Related]
8. Surgery after sunitinib administration to improve survival of patients with advanced pancreatic neuroendocrine neoplasms.
Murase Y; Kudo A; Akahoshi K; Maekawa A; Ishikawa Y; Ueda H; Ogawa K; Ono H; Tanaka S; Tanabe M
Ann Gastroenterol Surg; 2021 Sep; 5(5):692-700. PubMed ID: 34585054
[TBL] [Abstract][Full Text] [Related]
9. Role of ablation therapy in conjunction with surgical resection for neuroendocrine tumors involving the liver.
Ostapenko A; Stroever S; Eyasu L; Kim M; Aploks K; Dong XD; Seshadri R
World J Gastrointest Surg; 2024 Mar; 16(3):768-776. PubMed ID: 38577070
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine Tumors of Unknown Primary in the Setting of Cytoreductive Hepatectomy.
Ammann M; Gudmundsdottir H; Hackl H; Antwi SKA; Santol J; Habermann EB; Thiels CA; Warner SG; Truty MJ; Kendrick ML; Smoot RL; Nagorney DM; Cleary SP; Halfdanarson TR; Starlinger PP
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38717544
[TBL] [Abstract][Full Text] [Related]
11. ASO Visual Abstract: Neuroendocrine Tumors of Unknown Primary in the Setting of Cytoreductive Hepatectomy.
Ammann M; Gudmundsdottir H; Hackl H; Adjei Antwi SK; Santol J; Habermann EB; Thiels CA; Warner SG; Truty MJ; Kendrick ML; Smoot RL; Nagorney DM; Cleary SP; Halfdanarson TR; Starlinger PP
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38809451
[No Abstract] [Full Text] [Related]
12. Surgical Management of Neuroendocrine Tumor Liver Metastases.
Tran CG; Sherman SK; Chandrasekharan C; Howe JR
Surg Oncol Clin N Am; 2021 Jan; 30(1):39-55. PubMed ID: 33220808
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine liver metastases: a contemporary review of treatment strategies.
Cloyd JM; Ejaz A; Konda B; Makary MS; Pawlik TM
Hepatobiliary Surg Nutr; 2020 Aug; 9(4):440-451. PubMed ID: 32832495
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of pancreatic neuroendocrine liver metastases.
Cloyd JM; Wiseman JT; Pawlik TM
J Gastrointest Oncol; 2020 Jun; 11(3):590-600. PubMed ID: 32655938
[TBL] [Abstract][Full Text] [Related]
15. Contemporary indications for and outcomes of hepatic resection for neuroendocrine liver metastases.
Scoville SD; Xourafas D; Ejaz AM; Tsung A; Pawlik T; Cloyd JM
World J Gastrointest Surg; 2020 Apr; 12(4):159-170. PubMed ID: 32426095
[TBL] [Abstract][Full Text] [Related]
16. Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs).
Scott AT; Breheny PJ; Keck KJ; Bellizzi AM; Dillon JS; O'Dorisio TM; Howe JR
Surgery; 2019 Jan; 165(1):166-175. PubMed ID: 30343949
[TBL] [Abstract][Full Text] [Related]
17. Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status on Overall Survival in Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma.
Endo Y; Sasaki K; Moazzam Z; Lima HA; Alaimo L; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Kitago M; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
Ann Surg Oncol; 2023 Apr; 30(4):2023-2032. PubMed ID: 36396868
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine liver metastasis from the small intestine: Is surgery beneficial for survival?
Selberherr A; Freermann S; Koperek O; Niederle MB; Riss P; Scheuba C; Niederle B
Orphanet J Rare Dis; 2021 Jan; 16(1):30. PubMed ID: 33446229
[TBL] [Abstract][Full Text] [Related]
19. Effects of tumor origins and therapeutic options on the prognosis of hepatic neuroendocrine tumors: A retrospective study.
Jiao X; Luan W; Peng X; Liu L; Zhang L; Zhou L
Medicine (Baltimore); 2020 Dec; 99(51):e23655. PubMed ID: 33371100
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine.
Rindi G; Wiedenmann B
Nat Rev Endocrinol; 2020 Oct; 16(10):590-607. PubMed ID: 32839579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
